Our blog features educational information and personal perspectives relevant to the hereditary cancer community.
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research, Cancer Treatment
Tags:
BRCA, Ovarian Cancer, Genetic Testing, BRCA1, BRCA2, PALB2, Pancreatic Cancer, ATM, Gene Panel Testing, Metastatic Breast Cancer, Ovarian Cancer Treatment, PARP Inhibitor, Cancer Research, Advanced Breast Cancer, Inherited Mutations, Prostate Cancer Treatment, Metastatic Prostate Cancer, Cancer Targeted Therapy
Most Recent
Prevent Cancer Dialogue makes an in-person return for 2022 conference
A new tool is helping families conduct life-saving conversations about hereditary cancer
The Tigerlily Foundation: Removing Barriers to Breast Cancer Care for the Black Community
African American Women Need to Know More About High-Risk Breast Cancer
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.